Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-14 12:19 pm Sale |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Avidity Partners Management LP | 0 0.000% |
-1,278,261![]() (Position Closed) |
Filing History |
2023-02-14 12:02 pm Purchase |
2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Avidity Partners Management LP | 5,150,000 9.000% |
2,127,210![]() (+70.37%) |
Filing History |
2023-02-02 3:15 pm Purchase |
2023-01-25 | 13G | Praxis Precision Medicines, Inc. PRAX |
Avidity Partners Management LP | 273,333 8.700% |
273,333![]() (New Position) |
Filing History |
2022-12-08 10:22 am Purchase |
2022-12-05 | 13G | Karyopharm Therapeutics Inc. KPTI |
Avidity Partners Management LP | 756,788 9.900% |
756,788![]() (New Position) |
Filing History |
2022-10-27 09:56 am Purchase |
2022-10-26 | 13G | ESSA Pharma Inc. EPIX |
Avidity Partners Management LP | 3,750,000 8.500% |
3,750,000![]() (New Position) |
Filing History |
2022-09-20 4:35 pm Purchase |
2022-09-16 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Avidity Partners Management LP | 2,120,000 9.900% |
2,120,000![]() (New Position) |
Filing History |
2022-09-16 10:16 am Purchase |
2022-09-15 | 13G | Akero Therapeutics, Inc. AKRO |
Avidity Partners Management LP | 3,105,000 6.900% |
3,105,000![]() (New Position) |
Filing History |
2022-06-16 4:38 pm Purchase |
2022-06-15 | 13G | Arvinas, Inc. ARVN |
Avidity Partners Management LP | 3,239,838 6.100% |
3,239,838![]() (New Position) |
Filing History |
2022-02-14 09:18 am Purchase |
2021-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
Avidity Partners Management LP | 2,553,000 6.600% |
82,821![]() (+3.35%) |
Filing History |
2022-02-11 8:54 pm Purchase |
2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Avidity Partners Management LP | 5,244,019 9.900% |
494,019![]() (+10.40%) |
Filing History |
2022-02-11 8:39 pm Purchase |
2021-12-31 | 13G | SCYNEXIS, Inc. SCYX |
Avidity Partners Management LP | 2,239,278 9.300% |
259,478![]() (+13.11%) |
Filing History |
2022-02-11 8:34 pm Purchase |
2021-12-31 | 13G | OncoSec Medical Incorporated ONCS |
Avidity Partners Management LP | 133,864 7.500% |
45,136![]() (+50.87%) |
Filing History |
2022-02-11 8:18 pm Purchase |
2021-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Avidity Partners Management LP | 2,205,687 7.300% |
735,297![]() (+50.01%) |
Filing History |
2022-02-11 8:10 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Avidity Partners Management LP | 1,278,261 5.900% |
1,278,261![]() (New Position) |
Filing History |
2022-02-11 7:52 pm Purchase |
2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Avidity Partners Management LP | 4,405,000 9.200% |
120,000![]() (+2.80%) |
Filing History |
2022-02-11 7:43 pm Sale |
2021-12-31 | 13G | IVERIC bio, Inc. ISEE |
Avidity Partners Management LP | 6,955,000 6.100% |
-270,000![]() (-3.74%) |
Filing History |
2022-02-11 7:18 pm Purchase |
2021-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
Avidity Partners Management LP | 6,990,194 9.900% |
2,443,380![]() (+53.74%) |
Filing History |
2022-02-11 7:12 pm Sale |
2021-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
Avidity Partners Management LP | 0 0.000% |
-2,153,600![]() (Position Closed) |
Filing History |
2022-02-11 6:54 pm Sale |
2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
Avidity Partners Management LP | 0 0.000% |
-731,000![]() (Position Closed) |
Filing History |
2022-02-11 6:31 pm Purchase |
2021-12-31 | 13G | Adicet Bio, Inc. ACET |
Avidity Partners Management LP | 3,034,004 7.900% |
1,174,004![]() (+63.12%) |
Filing History |